References
- Shchendrygina A, Nagel E, Puntmann VO, et al. COVID-19 myocarditis and prospective heart failure burden. Expert Rev Cardiovasc Ther. 2021 Jan;19(1):5–14.
- Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020 May-Jun;14(3):247–250.
- Becker RC. Anticipating the long-term cardiovascular effects of COVID-19. J Thromb Thrombolysis. 2020 Oct;50(3):512–524.
- Siripanthong B, Nazarian S, Muser D, et al. Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020 Sep;17(9):1463–1471.
- Gassen N, Papies J, Bajaj T, et al. Analysis of SARS-CoV2-controlled autophagy reveals spermidine, MK-2206, and niclosamide as putative antiviral therapeutics. bioRxiv 2020.04.15.997254
- Chen X, Wang K, Xing Y, et al. Coronavirus membrane-associated papain-like proteases induce autophagy through interacting with Beclin1 to negatively regulate antiviral innate immunity. Protein Cell. 2014;5:912–927.
- Zhao Z, Lu K, Mao B, et al. The interplay between emerging human coronavirus infections and autophagy. Emerg Microbes Infect. 2021;10(1):196–205.
- Zhu H, He L. Beclin-1 biology and its role in heart disease. Curr Cardiol Rev. 2015;11(3):229–237.
- Niu TK, Cheng Y, Ren X, et al. Interaction of Beclin 1 with survivin regulates sensitivity of human glioma cells to TRAIL-induced apoptosis. FEBS Lett. 2010 Aug 20;584(16):3519–3524.
- Xu YX, Huang C, Liu M, et al. Survivin regulated by autophagy mediates hyperglycemia-induced vascular endothelial cell dysfunction. Exp Cell Res. 2018 Mar 15;364(2):152–159.
- Santini D, Abbate A, Scarpa S, et al. Survivin acute myocardial infarction: survivin expression in viable cardiomyocytes after infarction. J Clin Pathol. 2004 Dec;57(12):1321–1324.
- Lee PJ, Rudenko D, Kuliszewski MA, et al. Survivin gene therapy attenuates left ventricular systolic dysfunction in doxorubicin cardiomyopathy by reducing apoptosis and fibrosis. Cardiovasc Res. 2014 Mar 1;101(3):423–433.
- Tu SP, Quante M, Bhagat G, et al. IFN-γ inhibits gastric carcinogenesis by inducing epithelial cell autophagy and T-cell apoptosis. Cancer Res. 2011 Jun 15;71(12):4247–4259.
- Cosper PF, Harvey PA, Leinwand LA. Interferon-γ causes cardiac myocyte atrophy via selective degradation of myosin heavy chain in a model of chronic myocarditis. Am J Pathol. 2012 Dec;181(6):2038–2046.
- Gadotti AC, De Castro Deus M, Telles JP, et al. IFN-γ is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection. Virus Res. 2020 Nov;289:198171.